+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Immunogenic variants obtained by mutagenesis of mouse masto cytoma p 815 6. occasional escape from host rejection due to antigen loss secondary variants



Immunogenic variants obtained by mutagenesis of mouse masto cytoma p 815 6. occasional escape from host rejection due to antigen loss secondary variants



International Journal of Cancer 31(1): 119-124



After mutagenesis of mouse mastocytoma P815, it is possible to obtain variant (tum-) clones that are almost always rejected by syngeneic DBA/2 mice. Most tum- clones express new variant-specific antigens that can be detected by cytolytic T cells (CTL). Occasionally, mice injected with tum- variants eventually develop progressive tumors. Cells from these tumors were analyzed for antigen expression with variant-specific and P815-specific CTL clones. Out of 13 tumors examined, 11 were composed of cells that had clearly lost a variant-specific antigenic determinant. Tum- variants induce a specific host rejection response which usually results in complete elimination of the variant cells, but occasional antigen-loss constitutes an important mechanism of escape. The loss of a variant-specific antigenic determinant from 1 tum- clone that had escaped rejection allowed the detection of a residual variant-specific determinant. This was demonstrated by isolating a new CTL clone that lysed both the original tum- clone and its antigen-loss variant, but not other P815 targets. Some complex transplantation antigens apparently can be separated into independent determinants by using antigen-loss variants.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 005630568

Download citation: RISBibTeXText

PMID: 6187698


Related references

Immunogenic variants obtained by mutagenesis of mouse masto cytoma p 815 1. rejection by syngeneic mice. Journal of Experimental Medicine 152(5): 1175-1183, 1980

Immunogenic variants obtained by mutagenesis of mouse masto cytoma p 815 2. t lymphocyte mediated cytolysis. Journal of Experimental Medicine 152(5): 1184-1193, 1980

Immunogenic variants obtained by mutagenesis by mouse masto cytoma p 815 7. dominant expression of variant antigens in somatic cell hybrids. Somatic Cell Genetics 9(3): 345-358, 1983

Dissection of new antigens expressed on immunogenic variants of masto cytoma p 815 that were obtained by mutagenesis. Immunobiology 163(2-4): 144-145, 1982

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. IV. Analysis of variant-specific antigens by selection of antigen-loss variants with cytolytic T cell clones. European Journal of Immunology 12(5): 406-412, 1982

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice. Journal of Experimental Medicine 152(5): 1175-1183, 1980

Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression. Journal of Experimental Medicine 157(3): 1040-1052, 1983

Immunogenic (tum-) variants obtained by mutagenesis of mouse mastocytoma P815. VIII. Detection of stable transfectants expressing a tum- antigen with a cytolytic T cell stimulation assay. Immunogenetics 26(3): 178-187, 1987

Protection against two spontaneous mouse leukemias conferred by immunogenic variants obtained by mutagenesis. Journal of Experimental Medicine 157(6): 1992-2001, 1983

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. Ii. T lymphocyte-mediated cytolysis. Journal of Experimental Medicine 152(5): 1184-1193, 1980

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. V. H-2 associativity of variant-specific antigens. European Journal of Immunology 12(11): 905-908, 1982

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. III. Clonal analysis of the syngeneic cytolytic T lymphocyte response. European Journal of Immunology 12(5): 401-406, 1982

Immunogenic variants obtained by mutagenesis of mouse Lewis lung carcinoma. Recognition of variant-specific antigens by cytolytic T lymphocytes. European Journal of Cancer and Clinical Oncology 18(9): 867-874, 1982

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. VII. Dominant expression of variant antigens in somatic cell hybrids. Somatic Cell Genetics 9(3): 345-357, 1983

Immunogenic tumor cell variants obtained by mutagenesis. Archives de Biologie 92(4): 517-519, 1981